Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
≤0.06 - 1 |
Ranbezolid (RBX 7644) |
72 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
≤0.06 - 1 |
Ranbezolid (RBX 7644) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
0.5 |
0.125 - 32 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
4 |
≤0.06 - >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
4 |
≤0.06 - 16 |
Levofloxacin (Levaquin, Quixin) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.125 |
32 |
0.125 - 64 |
Gentamicin (Gentamycin, Garamycin) |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 - 0.25 |
Telavancin (TD-6424, Vibativ) |
73 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 - 0.5 |
Levofloxacin (Levaquin, Quixin) |
175 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 - 0.5 |
Tigecycline (GAR-936, Tigacyl) |
89 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 - 4 |
Gatifloxacin (Tequin) |
102 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 - 8 |
Levofloxacin (Levaquin, Quixin) |
117 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.25 |
0.12 - >32 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
16 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.03 - 0.5 |
Daptomycin + 50 μg/ml Ca++ |
67 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.03 - 0.5 |
Daptomycin + 75 μg/ml Ca++ |
67 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.12 - 64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
117 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 - 1 |
Tigecycline (GAR-936, Tigacyl) |
175 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
≤0.25 - 4 |
Levofloxacin (Levaquin, Quixin) |
371 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 - >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
175 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 - 8 |
Levofloxacin (Levaquin, Quixin) |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 - >32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.5 |
0.25 - >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
89 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
0.75 |
0.03 - 1 |
Ceftobiprole (Zeftera) |
162 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
1 |
0.03 - 2 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
1 |
0.06 - 2 |
Teicoplanin (Targocid) |
16 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
1 |
0.063 - 1 |
Vancomycin (Vancocyn, Lyphocin) |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
2 |
≤0.015 - 8 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
371 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
2 |
≤0.25 - 2 |
Zosyn |
371 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
4 |
0.06 - 32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |